An innovative CRO partner to support your novel therapeutic modality

Nucleic acid therapeutics (NATs) are changing the drug development landscape with their innovative approaches to treating diseases at the genetic level. At Celerion, we stay at the forefront of the CRO industry, ensuring that our bioanalytical services are as cutting-edge as the therapeutics we support.


PCR tube strip on thermal cycler for DNA amplification

Celerion has comprehensive PK expertise for your NAT program


NATs can exist as a range of structures including siRNA, antisense oligonucleotides, mRNAs, and DNA-based therapeutics. Bioanalytical methods to quantitatively detect NATs are therefore varied, too. At Celerion, we have hands-on expertise in pharmacokinetics across platforms to provide support for your molecule, whether that requires LC/MS, qPCR, or hybridization ELISA.

Celerion’s detailed methods and expert scientists make the difference


Sample handling and extraction procedures for NAT methods are of utmost importance in study design. At Celerion, we have decades of experience tailoring our methods to ensure stability of reagents and analytes while maximizing assay performance, all within a regulated setting.

RNA DNA molecular render

Visit our resources page to find case studies and scientific presentations showcasing our thoughtful, scientifically driven approaches to assay development across PK, immunogenicity, and biomarker methods.

Ready to Get Started?

Contact Celerion to Learn More

Contact Us